BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35509981)

  • 41. Prognostic model of lung adenocarcinoma constructed by the CENPA complex genes is closely related to immune infiltration.
    Zhou H; Bian T; Qian L; Zhao C; Zhang W; Zheng M; Zhou H; Liu L; Sun H; Li X; Zhang J; Liu Y
    Pathol Res Pract; 2021 Dec; 228():153680. PubMed ID: 34798483
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification and verification of a prognostic ferroptosis-related lncRNAs signature for patients with lung adenocarcinoma.
    Qi K; Liu XL; Chen XL; Song C; Peng JH; Xu JJ
    Am J Transl Res; 2022; 14(6):3698-3715. PubMed ID: 35836852
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Establishment of a ferroptosis-related gene signature for prognosis in lung adenocarcinoma patients.
    Cai J; Li C; Li H; Wang X; Zhou Y
    PeerJ; 2021; 9():e11931. PubMed ID: 34434660
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dysregulated ferroptosis-related genes indicate potential clinical benefits for anti-PD-1/PD-L1 immunotherapy in lung adenocarcinoma.
    Zhou M; Zhang X; Li T; Chen Y
    J Clin Lab Anal; 2021 Dec; 35(12):e24086. PubMed ID: 34752672
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PHGDH Inhibits Ferroptosis and Promotes Malignant Progression by Upregulating SLC7A11 in Bladder Cancer.
    Shen L; Zhang J; Zheng Z; Yang F; Liu S; Wu Y; Chen Y; Xu T; Mao S; Yan Y; Li W; Zhang W; Yao X
    Int J Biol Sci; 2022; 18(14):5459-5474. PubMed ID: 36147463
    [No Abstract]   [Full Text] [Related]  

  • 46. TRIM3 facilitates ferroptosis in non-small cell lung cancer through promoting SLC7A11/xCT K11-linked ubiquitination and degradation.
    Wang Z; Shen N; Wang Z; Yu L; Yang S; Wang Y; Liu Y; Han G; Zhang Q
    Cell Death Differ; 2024 Jan; 31(1):53-64. PubMed ID: 37978273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. H2A Histone Family Member Z (H2AFZ) Serves as a Prognostic Biomarker in Lung Adenocarcinoma: Bioinformatic Analysis and Experimental Validation.
    Li Z; Hu M; Qiu J; Feng J; Zhang R; Wu H; Hu G; Ren J
    Med Sci Monit; 2022 Jan; 28():e933447. PubMed ID: 35027526
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genome‑wide investigation of the clinical significance and prospective molecular mechanisms of kinesin family member genes in patients with lung adenocarcinoma.
    Zhang L; Zhu G; Wang X; Liao X; Huang R; Huang C; Huang P; Zhang J; Wang P
    Oncol Rep; 2019 Sep; 42(3):1017-1034. PubMed ID: 31322267
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for lung adenocarcinoma.
    Gao L; Zhang L
    BMC Cancer; 2021 Jul; 21(1):849. PubMed ID: 34301211
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma.
    Zhai Y; Zhao B; Wang Y; Li L; Li J; Li X; Chang L; Chen Q; Liao Z
    BMC Cancer; 2021 Mar; 21(1):213. PubMed ID: 33648465
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of nine microRNAs as potential biomarkers for lung adenocarcinoma.
    Ren ZP; Hou XB; Tian XD; Guo JT; Zhang LB; Xue ZQ; Deng JQ; Zhang SW; Pan JY; Chu XY
    FEBS Open Bio; 2019 Feb; 9(2):315-327. PubMed ID: 30761256
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Establishment and Evaluation of a 6-Gene Survival Risk Assessment Model Related to Lung Adenocarcinoma Microenvironment.
    Wang Z; Xu H; Zhu L; He T; Lv W; Wu Z
    Biomed Res Int; 2020; 2020():6472153. PubMed ID: 32337264
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development and Validation of a Robust Ferroptosis-Related Prognostic Signature in Lung Adenocarcinoma.
    Zhang A; Yang J; Ma C; Li F; Luo H
    Front Cell Dev Biol; 2021; 9():616271. PubMed ID: 34249899
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Four Low Expression LncRNAs are Associated with Prognosis of Human Lung Adenocarcinoma.
    Shen XQ; Wu QM; Yang CH; Yan QD; Cao PJ; Chen FL
    Clin Lab; 2020 Oct; 66(10):. PubMed ID: 33073959
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
    Li J; Liu X; Cui Z; Han G
    Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High Expression of
    Deng H; Huang Y; Wang L; Chen M
    Biomed Res Int; 2020; 2020():2071593. PubMed ID: 33134373
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A new survival model based on ferroptosis-related genes for prognostic prediction in clear cell renal cell carcinoma.
    Wu G; Wang Q; Xu Y; Li Q; Cheng L
    Aging (Albany NY); 2020 Jul; 12(14):14933-14948. PubMed ID: 32688345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma.
    Zhao Z; He B; Cai Q; Zhang P; Peng X; Zhang Y; Xie H; Wang X
    Int Immunopharmacol; 2021 Sep; 98():107807. PubMed ID: 34175739
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic value of immune-related genes in the tumor microenvironment of lung adenocarcinoma and lung squamous cell carcinoma.
    Qu Y; Cheng B; Shao N; Jia Y; Song Q; Tan B; Wang J
    Aging (Albany NY); 2020 Mar; 12(6):4757-4777. PubMed ID: 32209727
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
    Wang W; Ren S; Wang Z; Zhang C; Huang J
    Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.